Issue 48, 2012

Expression of recombinant human flavin monooxygenase and moclobemide-N-oxide synthesis on multi-mg scale

Abstract

A panel of human flavin monooxygenases were heterologously expressed in E. coli to obtain ready-to-use biocatalysts for the in vitro preparation of human drug metabolites. Moclobemide-N-oxide (65 mg) was the first high-priced metabolite prepared with recombinant hFMO3 on the multi-milligram scale.

Graphical abstract: Expression of recombinant human flavin monooxygenase and moclobemide-N-oxide synthesis on multi-mg scale

Supplementary files

Article information

Article type
Communication
Submitted
16 Dec 2011
Accepted
25 Apr 2012
First published
25 Apr 2012

Chem. Commun., 2012,48, 6001-6003

Expression of recombinant human flavin monooxygenase and moclobemide-N-oxide synthesis on multi-mg scale

S. P. Hanlon, A. Camattari, S. Abad, A. Glieder, M. Kittelmann, S. Lütz, B. Wirz and M. Winkler, Chem. Commun., 2012, 48, 6001 DOI: 10.1039/C2CC17878H

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements